EFTA02451831

From: jeffrey E. <[email protected]> Sent: Saturday, September 10, 2016 5:33 AM To: Ssulayem Subject: Re: Drug That Might Double Life-Expectancy Is Under Trial many of my friends take it. it does make=a differnece if you are dibbeitic =div class="gmail_quote">On Sat, Sep 10, 2016 at 1:00 AM, Ssulayem <[email protected] <mailto:[email protected]> > wrote: What do=you think is this true? http://www.ba-bamail.=om/content.aspx?emailid=22477&source=mobile_share <http://www.ba- bamail.com/content.aspx?emailid=22477&source=3Dmobile_share> Sent from my iPhone =AO please note The information contained i= this communication is confidential, may be attorney-client privileged,=may constitute inside information, and is intended only for the use =f the addressee. It is the property of JEE Unauthorized use, disclos=re or copying of this communication or any part thereof is strictly pro=ibited and may be unlawful. If you have received this communication =n error, please notify us immediately by return e-mail or by e-mail to =a href="mailto:[email protected]" target="_blank">jeevacation@gmai=.com, and destroy this communication and all copies thereof, inc=uding all attachments. copyright -all rights reserved --001a113eeb181cf642053c209ad4-- conversation-id 70108 date-last-viewed 0 date-received 1473485605 flags 8590195713 gmail-label-ids 7 remote-id 643203 EFTA_R1_01551621 EFTA02451831